Interview with Katrin Haeverans

What is your current role in EPAD? As a Janssen employee, I support the EPAD team from an operational perspective. I hope to bring my experience and can help building the EPAD POC platform so that it’s ready to welcome the first Intervention Owners in 2018 and beyond! What did you do prior to joining…

Interview with Joseph Milne

What is your current role in EPAD? I am the project manager for the EPAD Longitudinal Cohort Study (LCS) at IQVIA, formally Quintiles.  As all of the EPAD team will know, IQVIA have very recently been given an enhanced role in the LCS study.  This has given me a much broader scope in the study,…

Highlights 2017

    With the beginning of this new year, the EPAD project is celebrating it’s 3rd birthday. We are proud to look back at a lot of successful deliveries. We list herein some of our key highlights of the past 12 months. We are looking forward to doing even better this year! Wishing you all…

EPAD presented at the Alzheimer Europe Academy

On 5 and 6 December 2017, Alzheimer Europe (AE) hosted its third annual Alzheimer’s Association Academy in Brussels, Belgium. The meeting was attended by 49 participants including representatives from AE member organisations, national Alzheimer associations and company. There were 14 expert speakers on the packed agenda. The two-day Academy was a highly interactive event, with lots of…

The Scottish Dementia Research Consortium is looking for members

Our project leader Professor Craig Ritchie (pictured) is the new Chair of the Scottish Dementia Research Consortium (SDRC). SDRC is a membership based organisation which aims to support the development and expansion of high quality, co-ordinated, collaborative dementia research throughout Scotland. On 29 November, Alzheimer Scotland published an article on its website entitled “Help shape…

EPAD opens six new study sites

The European Prevention of Alzheimer’s Dementia Consortium (EPAD) is recruiting research participants at six new sites, bringing the total to ten centres in six European countries. People in France, the Netherlands, Spain, Sweden, Switzerland and UK can now take part in the study, which aims to develop tests to identify early signs of Alzheimer’s disease…